Refractory Chronic Rhinosinusitis.
Tabaee A, McCoul ED.
Otolaryngol Clin North Am. 2017 Feb;50(1):xvii-xviii. doi: 10.1016/j.otc.2016.11.001.
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, Smith SG, Martin N, Mayer B, Yancey SW, Sousa AR, Chan R, Hopkins C; SYNAPSE study investigators.
Lancet Respir Med. 2021 Oct;9(10):1141-1153. doi: 10.1016/S2213-2600(21)00097-7. Epub 2021 Apr 16.
Real-Life Effectiveness of Mepolizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps.
Domínguez-Sosa MS, Cabrera-Ramírez MS, Marrero-Ramos MDC, Dávila-Quintana D, Cabrera-López C, Carrillo-Díaz T, Del Rosario JJB.
Biomedicines. 2023 Feb 8;11(2):485. doi: 10.3390/biomedicines11020485.
Refractory Chronic Rhinosinusitis with Nasal Polyposis.
Hull BP, Chandra RK.
Otolaryngol Clin North Am. 2017 Feb;50(1):61-81. doi: 10.1016/j.otc.2016.08.006.
Chronic Rhinosinusitis.
Keating MK, Phillips JC, Phillips J.
Am Fam Physician. 2023 Oct;108(4):370-377.
Management of chronic refractory cough in adults.
Visca D, Beghè B, Fabbri LM, Papi A, Spanevello A.
Eur J Intern Med. 2020 Nov;81:15-21. doi: 10.1016/j.ejim.2020.09.008. Epub 2020 Sep 19.
Medical therapy, refractory chronic rhinosinusitis, and productivity costs.
Smith KA, Rudmik L.
Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):5-11. doi: 10.1097/ACI.0000000000000329.
Topical Therapies for Refractory Chronic Rhinosinusitis.
Sanan A, Rabinowitz M, Rosen M, Nyquist G.
Otolaryngol Clin North Am. 2017 Feb;50(1):129-141. doi: 10.1016/j.otc.2016.08.011.
Office Procedures in Refractory Chronic Rhinosinusitis.
Thamboo A, Patel ZM.
Otolaryngol Clin North Am. 2017 Feb;50(1):113-128. doi: 10.1016/j.otc.2016.08.010.
Biofilm and Osteitis in Refractory Chronic Rhinosinusitis.
Zhao YC, Wormald PJ.
Otolaryngol Clin North Am. 2017 Feb;50(1):49-60. doi: 10.1016/j.otc.2016.08.005.
